Medicare Enrolled

Dr. Sharad Lakhanpal, M.D.

Optician · Dallas, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
8144 WALNUT HILL LN, Dallas, TX 75231
2145400700
In practice since 2005 (20 years)
NPI: 1720087414 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lakhanpal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lakhanpal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lakhanpal

Dr. Sharad Lakhanpal is an optician specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lakhanpal performed 160,222 Medicare services across 5,070 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lakhanpal received a total of $224,314 from 16 pharmaceutical and/or device companies across 438 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lakhanpal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 0% volume in TX $224,314 industry payments

Medicare Practice Summary

Medicare Utilization ↗
160,222
Medicare services
Top 0% in TX for optician
5,070
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,011 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
145,600 $4 $15
Denosumab injection (Prolia/Xgeva) 2,700 $18 $69
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,172 $94 $377
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
1,151 $7 $23
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
1,150 $8 $27
Sed rate test (inflammation marker)
This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body.
1,145 $3 $8
C-reactive protein test (inflammation marker)
A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body.
1,142 $5 $15
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
1,141 $10 $32
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
768 $60 $217
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
590 $2 $7
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
520 $3 $10
Complement and antigen measurement
A laboratory test to measure levels of complement proteins and antigens in the blood.
336 $12 $36
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
298 $28 $88
Autoimmune disorder antibody test
A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders.
282 $17 $54
Uric acid level test
A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines.
222 $4 $14
Rheumatoid arthritis antibody test
A blood test to measure antibodies used in assessing rheumatoid arthritis.
209 $12 $39
Rheumatoid factor level 209 $5 $17
Beta 2 glycoprotein 1 antibody (autoantibody) measurement 208 $24 $76
Cardiolipin antibody (tissue antibody) measurement 208 $24 $76
Autoimmune disorder screening test
A laboratory test used to screen for the presence of autoimmune disorders.
170 $12 $36
Screening test for antibody to noninfectious agent
A laboratory test that screens for the presence of antibodies produced in response to a noninfectious agent.
168 $12 $36
X-ray of hand, minimum of 3 views
An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints.
103 $31 $111
Hepatitis C antibody test
A blood test that checks for antibodies to the hepatitis C virus. This test helps determine if a person has been exposed to the virus.
78 $13 $43
New patient office visit, complex (60-74 min) 78 $163 $649
Hepatitis B core antibody test
A blood test that measures the level of antibodies to the hepatitis B core antigen. This test helps determine if a person has been infected with the hepatitis B virus.
76 $11 $36
Hepatitis B surface antibody test
A blood test that measures the level of antibodies against the hepatitis B surface antigen. This test is used to check for immunity to hepatitis B or to verify the effectiveness of the hepatitis B vaccine.
76 $10 $32
Hepatitis B surface antigen test
A blood test that uses an immunoassay technique to detect the presence of the hepatitis B surface antigen. This test identifies whether the hepatitis B virus is currently present in the body.
76 $10 $31
Foot X-ray, 3+ views
An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints.
54 $28 $103
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
40 $48 $191
X-ray of both knees, standing
An X-ray image of both knees taken while the patient is standing to assess bone alignment and joint space under weight-bearing conditions.
40 $33 $123
Injection, methylprednisolone acetate, 40 mg 36 $5 $24
X-ray of upper spine, 2-3 views
An X-ray imaging test of the upper spine using two to three different angles to visualize the bones and structures.
32 $33 $120
X-ray of lower and sacral spine, 2-3 views
An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area.
29 $33 $120
Shoulder X-ray, 2+ views
An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures.
29 $29 $104
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
27 $13 $41
Cardiac enzyme level (CK-MB) test
A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage.
21 $6 $19
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
13 $145 $506
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
13 $31 $80
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
12 $72 $587
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$224,314
Total received (2018-2024)
Avg $32,045/year across 7 years
Top 2% in TX for optician
16
Companies
438
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$221,555 (98.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,459 (0.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,300 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$10,302
2023
$7,070
2022
$23,463
2021
$34,310
2020
$40,490
2019
$94,635
2018
$14,044

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AbbVie Inc.
$73,055
AbbVie, Inc.
$62,460
Novartis Pharmaceuticals Corporation
$42,481
ABBVIE INC.
$40,364
Horizon Therapeutics plc
$3,294
McKesson Specialty Care Distribution, LLC
$1,300
Janssen Biotech, Inc.
$369
PFIZER INC.
$311
GlaxoSmithKline, LLC.
$280
Genentech USA, Inc.
$132
Amgen Inc.
$99
E.R. Squibb & Sons, L.L.C.
$74
UCB, Inc.
$36
Kiniksa Pharmaceuticals International, plc
$31
Horizon Pharma plc
$13
Bioventus LLC
$13
Top 3 companies account for 79.4% of total payments
Associated products mentioned in payments ›
Actemra · Arcalyst · BENLYSTA · COSENTYX · Cimzia · EVENITY · GELSYN-3 · HUMIRA · Humira · INFLECTRA · KRYSTEXXA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORENCIA · RAYOS · REMICADE · RINVOQ · Rinvoq · Rituxan · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (99%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for optician in TX.

Equivalent to $140 per 100 Medicare services performed
Looking for an optician specialist in Dallas?
Compare opticians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
504
Per 100K population
19.4
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lakhanpal is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with speaking/promotional industry engagement in the top 2% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lakhanpal experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Lakhanpal performed 145,600 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lakhanpal receive payments from pharmaceutical companies?
Yes. Dr. Lakhanpal received a total of $224,314 from 16 companies across 438 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lakhanpal's costs compare to other opticians in Dallas?
Dr. Lakhanpal's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lakhanpal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →